Results for tag: "Icosapent"

Icosapent is a prescription drug used to reduce triglyceride levels in adults with severe hypertriglyceridemia. It is a purified form of eicosapentaenoic acid (EPA), an omega-3 fatty acid found in fish oil. Icosapent is approved by the U.S. Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia. It is also approved for use in combination with statins to reduce the risk of cardiovascular events in adults with elevated triglyceride levels. Icosapent is part of a larger class of cardiovascular drugs known as lipid-lowering agents. These drugs are used to reduce the risk of cardiovascular disease by lowering levels of low-density lipoprotein (LDL) cholesterol, total cholesterol, and triglycerides. Icosapent is the only FDA-approved omega-3 fatty acid for this purpose. The icosapent market is highly competitive, with several major pharmaceutical companies offering products. These include Amarin Corporation, AstraZeneca, GlaxoSmithKline, Merck & Co., and Pfizer. Show Less Read more